{"entity":{"type":"insider","cik":"0001724605","url":"/insider/0001724605","json_url":"/insider/0001724605.json","name":"Ho Carole","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":117,"n_filings":51,"first":"2018-08-31","last":"2025-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Ho Carole","source":"filing","n_filings":51,"first_seen":"2018-08-31","last_seen":"2025-08-14"}],"transactions":[{"id":4743499,"accession":"0001714899-25-000176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-25-000176","line_url":"/filing/0001714899-25-000176#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":806.0,"shares_display":"806","price_per_share":14.64,"price_display":"14.64","price_state":"stated","total_value":11799.84,"total_display":"11,799.84","total_whole":"11,800","shares_owned_after":216585.0,"shares_owned_after_display":"216,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-14","scope":"insider"},{"id":4743496,"accession":"0001714899-25-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-25-000176","line_url":"/filing/0001714899-25-000176#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2937.0,"shares_display":"2,937","price_per_share":13.58,"price_display":"13.58","price_state":"stated","total_value":39884.46,"total_display":"39,884.46","total_whole":"39,884","shares_owned_after":217391.0,"shares_owned_after_display":"217,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":5177237,"accession":"0001714899-25-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-25-000051","line_url":"/filing/0001714899-25-000051#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2907.0,"shares_display":"2,907","price_per_share":20.81,"price_display":"20.81","price_state":"stated","total_value":60494.67,"total_display":"60,494.67","total_whole":"60,495","shares_owned_after":175673.0,"shares_owned_after_display":"175,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-08","scope":"insider"},{"id":5177233,"accession":"0001714899-25-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-25-000051","line_url":"/filing/0001714899-25-000051#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12255.0,"shares_display":"12,255","price_per_share":20.22,"price_display":"20.22","price_state":"stated","total_value":247796.1,"total_display":"247,796.10","total_whole":"247,796","shares_owned_after":178580.0,"shares_owned_after_display":"178,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-08","scope":"insider"},{"id":2443871,"accession":"0001714899-24-000194","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001714899-24-000194","line_url":"/filing/0001714899-24-000194","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20005.0,"shares_display":"20,005","price_per_share":24.57240189952512,"price_display":"24.57","price_state":"stated","total_value":491570.9,"total_display":"491,570.90","total_whole":"491,571","shares_owned_after":124717.0,"shares_owned_after_display":"124,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-22","scope":"insider","n_lines":2},{"id":2443865,"accession":"0001714899-24-000194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000194","line_url":"/filing/0001714899-24-000194#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2453.0,"shares_display":"2,453","price_per_share":23.79,"price_display":"23.79","price_state":"stated","total_value":58356.87,"total_display":"58,356.87","total_whole":"58,357","shares_owned_after":138815.0,"shares_owned_after_display":"138,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":2523402,"accession":"0001714899-24-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000176","line_url":"/filing/0001714899-24-000176#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2337.0,"shares_display":"2,337","price_per_share":22.89,"price_display":"22.89","price_state":"stated","total_value":53493.93,"total_display":"53,493.93","total_whole":"53,494","shares_owned_after":141268.0,"shares_owned_after_display":"141,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider"},{"id":2366523,"accession":"0001714899-24-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-24-000060","line_url":"/filing/0001714899-24-000060#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":17.79,"price_display":"17.79","price_state":"stated","total_value":24994.95,"total_display":"24,994.95","total_whole":"24,995","shares_owned_after":143605.0,"shares_owned_after_display":"143,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-15","scope":"insider"},{"id":2366521,"accession":"0001714899-24-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000060","line_url":"/filing/0001714899-24-000060#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2784.0,"shares_display":"2,784","price_per_share":17.29,"price_display":"17.29","price_state":"stated","total_value":48135.36,"total_display":"48,135.36","total_whole":"48,135","shares_owned_after":145010.0,"shares_owned_after_display":"145,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2125107,"accession":"0001714899-24-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000040","line_url":"/filing/0001714899-24-000040#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4668.0,"shares_display":"4,668","price_per_share":19.02,"price_display":"19.02","price_state":"stated","total_value":88785.36,"total_display":"88,785.36","total_whole":"88,785","shares_owned_after":147794.0,"shares_owned_after_display":"147,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-12","scope":"insider"},{"id":2227413,"accession":"0001714899-24-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-24-000038","line_url":"/filing/0001714899-24-000038#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9972.0,"shares_display":"9,972","price_per_share":19.43,"price_display":"19.43","price_state":"stated","total_value":193755.96,"total_display":"193,755.96","total_whole":"193,756","shares_owned_after":198777.0,"shares_owned_after_display":"198,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":8738287,"accession":"0001714899-23-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000136","line_url":"/filing/0001714899-23-000136#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2522.0,"shares_display":"2,522","price_per_share":23.22,"price_display":"23.22","price_state":"stated","total_value":58560.84,"total_display":"58,560.84","total_whole":"58,561","shares_owned_after":182809.0,"shares_owned_after_display":"182,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-23","filed_date":"2023-08-25","scope":"insider"},{"id":8344892,"accession":"0001714899-23-000135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000135","line_url":"/filing/0001714899-23-000135#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2478.0,"shares_display":"2,478","price_per_share":22.6,"price_display":"22.60","price_state":"stated","total_value":56002.8,"total_display":"56,002.80","total_whole":"56,003","shares_owned_after":185331.0,"shares_owned_after_display":"185,331","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8691386,"accession":"0001714899-23-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000125","line_url":"/filing/0001714899-23-000125#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2768.0,"shares_display":"2,768","price_per_share":23.79,"price_display":"23.79","price_state":"stated","total_value":65850.72,"total_display":"65,850.72","total_whole":"65,851","shares_owned_after":182809.0,"shares_owned_after_display":"182,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-16","scope":"insider"},{"id":8181780,"accession":"0001714899-23-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000122","line_url":"/filing/0001714899-23-000122#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2857.0,"shares_display":"2,857","price_per_share":24.15,"price_display":"24.15","price_state":"stated","total_value":68996.55,"total_display":"68,996.55","total_whole":"68,997","shares_owned_after":185577.0,"shares_owned_after_display":"185,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider"},{"id":8270011,"accession":"0001714899-23-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000033","line_url":"/filing/0001714899-23-000033#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1476.0,"shares_display":"1,476","price_per_share":29.4,"price_display":"29.40","price_state":"stated","total_value":43394.4,"total_display":"43,394.40","total_whole":"43,394","shares_owned_after":182809.0,"shares_owned_after_display":"182,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-17","scope":"insider"},{"id":8757214,"accession":"0001714899-23-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-23-000025","line_url":"/filing/0001714899-23-000025#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2548.0,"shares_display":"2,548","price_per_share":30.1,"price_display":"30.10","price_state":"stated","total_value":76694.8,"total_display":"76,694.80","total_whole":"76,695","shares_owned_after":184285.0,"shares_owned_after_display":"184,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider"},{"id":8757211,"accession":"0001714899-23-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000025","line_url":"/filing/0001714899-23-000025#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":818.0,"shares_display":"818","price_per_share":29.8,"price_display":"29.80","price_state":"stated","total_value":24376.4,"total_display":"24,376.40","total_whole":"24,376","shares_owned_after":179365.0,"shares_owned_after_display":"179,365","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-14","scope":"insider"},{"id":8489220,"accession":"0001714899-23-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000021","line_url":"/filing/0001714899-23-000021#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1521.0,"shares_display":"1,521","price_per_share":30.88,"price_display":"30.88","price_state":"stated","total_value":46968.48,"total_display":"46,968.48","total_whole":"46,968","shares_owned_after":180183.0,"shares_owned_after_display":"180,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-10","scope":"insider"},{"id":8181779,"accession":"0001714899-23-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000017","line_url":"/filing/0001714899-23-000017#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1459.0,"shares_display":"1,459","price_per_share":28.48,"price_display":"28.48","price_state":"stated","total_value":41552.32,"total_display":"41,552.32","total_whole":"41,552","shares_owned_after":177454.0,"shares_owned_after_display":"177,454","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-10","scope":"insider"},{"id":8026282,"accession":"0001714899-23-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-23-000016","line_url":"/filing/0001714899-23-000016#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1451.0,"shares_display":"1,451","price_per_share":28.67,"price_display":"28.67","price_state":"stated","total_value":41600.17,"total_display":"41,600.17","total_whole":"41,600","shares_owned_after":178913.0,"shares_owned_after_display":"178,913","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-09","scope":"insider"},{"id":8026280,"accession":"0001714899-23-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-23-000016","line_url":"/filing/0001714899-23-000016#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2636.0,"shares_display":"2,636","price_per_share":28.44,"price_display":"28.44","price_state":"stated","total_value":74967.84,"total_display":"74,967.84","total_whole":"74,968","shares_owned_after":180364.0,"shares_owned_after_display":"180,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8461188,"accession":"0001209191-23-002184","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002184","line_url":"/filing/0001209191-23-002184#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2913.0,"shares_display":"2,913","price_per_share":28.69,"price_display":"28.69","price_state":"stated","total_value":83573.97,"total_display":"83,573.97","total_whole":"83,574","shares_owned_after":175500.0,"shares_owned_after_display":"175,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6260614,"accession":"0001714899-22-000130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000130","line_url":"/filing/0001714899-22-000130#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2424.0,"shares_display":"2,424","price_per_share":31.98,"price_display":"31.98","price_state":"stated","total_value":77519.52,"total_display":"77,519.52","total_whole":"77,520","shares_owned_after":170663.0,"shares_owned_after_display":"170,663","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-23","filed_date":"2022-08-25","scope":"insider"},{"id":6191667,"accession":"0001714899-22-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000126","line_url":"/filing/0001714899-22-000126#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2576.0,"shares_display":"2,576","price_per_share":33.22,"price_display":"33.22","price_state":"stated","total_value":85574.72,"total_display":"85,574.72","total_whole":"85,575","shares_owned_after":173087.0,"shares_owned_after_display":"173,087","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-23","scope":"insider"},{"id":6636355,"accession":"0001714899-22-000039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000039","line_url":"/filing/0001714899-22-000039#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2918.0,"shares_display":"2,918","price_per_share":34.71,"price_display":"34.71","price_state":"stated","total_value":101283.78,"total_display":"101,283.78","total_whole":"101,284","shares_owned_after":170663.0,"shares_owned_after_display":"170,663","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-15","scope":"insider"},{"id":6662227,"accession":"0001714899-22-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000033","line_url":"/filing/0001714899-22-000033#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1423.0,"shares_display":"1,423","price_per_share":37.0987,"price_display":"37.10","price_state":"stated","total_value":52791.4501,"total_display":"52,791.45","total_whole":"52,791","shares_owned_after":166112.0,"shares_owned_after_display":"166,112","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":6284134,"accession":"0001714899-22-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000006","line_url":"/filing/0001714899-22-000006#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2845.0,"shares_display":"2,845","price_per_share":44.78,"price_display":"44.78","price_state":"stated","total_value":127399.1,"total_display":"127,399.10","total_whole":"127,399","shares_owned_after":163285.0,"shares_owned_after_display":"163,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":5308495,"accession":"0001714899-21-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-21-000115","line_url":"/filing/0001714899-21-000115#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1476.0,"shares_display":"1,476","price_per_share":42.52,"price_display":"42.52","price_state":"stated","total_value":62759.52,"total_display":"62,759.52","total_whole":"62,760","shares_owned_after":76316.0,"shares_owned_after_display":"76,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-08","scope":"insider"},{"id":5534226,"accession":"0001714899-21-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-21-000088","line_url":"/filing/0001714899-21-000088#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6143.0,"shares_display":"6,143","price_per_share":48.91,"price_display":"48.91","price_state":"stated","total_value":300454.13,"total_display":"300,454.13","total_whole":"300,454","shares_owned_after":158630.0,"shares_owned_after_display":"158,630","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-25","scope":"insider"},{"id":4114496,"accession":"0001714899-21-000087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-21-000087","line_url":"/filing/0001714899-21-000087","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2546.0,"shares_display":"2,546","price_per_share":49.57959937156323,"price_display":"49.58","price_state":"stated","total_value":126229.66,"total_display":"126,229.66","total_whole":"126,230","shares_owned_after":165917.0,"shares_owned_after_display":"165,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-23","scope":"insider","n_lines":2},{"id":4092147,"accession":"0001209191-21-023846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-023846","line_url":"/filing/0001209191-21-023846#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2822.0,"shares_display":"2,822","price_per_share":54.616,"price_display":"54.62","price_state":"stated","total_value":154126.352,"total_display":"154,126.35","total_whole":"154,126","shares_owned_after":162319.0,"shares_owned_after_display":"162,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-29","filed_date":"2021-03-31","scope":"insider"},{"id":5322482,"accession":"0001209191-21-016857","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-016857","line_url":"/filing/0001209191-21-016857","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7092.0,"shares_display":"7,092","price_per_share":66.37633502538071,"price_display":"66.38","price_state":"stated","total_value":470740.968,"total_display":"470,740.97","total_whole":"470,741","shares_owned_after":168035.0,"shares_owned_after_display":"168,035","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider","n_lines":7},{"id":4612831,"accession":"0001209191-21-011010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-011010","line_url":"/filing/0001209191-21-011010","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3156.0,"shares_display":"3,156","price_per_share":70.33330038022814,"price_display":"70.33","price_state":"stated","total_value":221971.896,"total_display":"221,971.90","total_whole":"221,972","shares_owned_after":172633.0,"shares_owned_after_display":"172,633","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider","n_lines":2},{"id":5321436,"accession":"0001209191-21-009888","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009888","line_url":"/filing/0001209191-21-009888","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1470.0,"shares_display":"1,470","price_per_share":74.68335646258504,"price_display":"74.68","price_state":"stated","total_value":109784.534,"total_display":"109,784.53","total_whole":"109,785","shares_owned_after":168385.0,"shares_owned_after_display":"168,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider","n_lines":3},{"id":3324360,"accession":"0001209191-20-054727","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-054727","line_url":"/filing/0001209191-20-054727","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":41.220468333333336,"price_display":"41.22","price_state":"stated","total_value":1236614.05,"total_display":"1,236,614.05","total_whole":"1,236,614","shares_owned_after":166617.0,"shares_owned_after_display":"166,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-09","filed_date":"2020-10-13","scope":"insider","n_lines":2},{"id":3324345,"accession":"0001209191-20-054727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-054727","line_url":"/filing/0001209191-20-054727#line-2","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22906.0,"shares_display":"22,906","price_per_share":40.12,"price_display":"40.12","price_state":"stated","total_value":918988.72,"total_display":"918,988.72","total_whole":"918,989","shares_owned_after":166617.0,"shares_owned_after_display":"166,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-13","scope":"insider"},{"id":3091253,"accession":"0001209191-20-050357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-050357","line_url":"/filing/0001209191-20-050357#line-1","is_derivative":false,"issuer_cik":"0001714899","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001714899","owner_cik":"0001724605","owner_name":"Ho Carole","owner_display_name":"Ho Carole","owner_url":"/insider/0001724605","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3689.0,"shares_display":"3,689","price_per_share":31.0,"price_display":"31.00","price_state":"stated","total_value":114359.0,"total_display":"114,359.00","total_whole":"114,359","shares_owned_after":165141.0,"shares_owned_after_display":"165,141","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-14","scope":"insider"}],"collapsed":true,"next_cursor":"2020-09-10|3091253","ledger_fault":false,"count":{"value":117,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":117,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":117},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001714899","name":"Denali Therapeutics Inc.","url":"/issuer/0001714899","role":"Officer (Chief Medical Officer)","n_filings":51,"first_seen":"2018-08-31","last_seen":"2025-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001724605","retrieved_at":"2026-08-27T12:11:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}